Ιατρείο Γενικής Ιατρικής - Αλεπίδης Δημήτριος

  • Home
  • Cyprus
  • Limassol
  • Ιατρείο Γενικής Ιατρικής - Αλεπίδης Δημήτριος

Ιατρείο Γενικής Ιατρικής - Αλεπίδης Δημήτριος Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Ιατρείο Γενικής Ιατρικής - Αλεπίδης Δημήτριος, Doctor, 33 Spyrou kyprianou Avenue, Limassol.

Dimitrios Alepidis Medical Doctor, family medicine specialist, Masters on Holistic Alternative medical systems, medical acupuncture, classic Homeopathy, Secretary of family medicine association of Cyprus, online medical seminars

Για εγγραφές στον προσωπικό ιατρό,Θα με βρείτε στη Λεμεσό, λεωφόρο Σπύρου Κυπριανού 33, Swissmed Health Building
03/08/2026

Για εγγραφές στον προσωπικό ιατρό,
Θα με βρείτε στη Λεμεσό, λεωφόρο Σπύρου Κυπριανού 33, Swissmed Health Building

Εγγραφή προσωπικού ιατρούΕύκολα και γρήγορα.Με δύο βήματα
19/07/2026

Εγγραφή προσωπικού ιατρού

Εύκολα και γρήγορα.

Με δύο βήματα

21/06/2026
06/06/2026

Συνέδριο Γενικής Οικογένειακης Ιατρικής
13-14 Ιουνίου 2026
Πολιτιστικό κέντρο ευρωπαϊκού Πανεπιστήμιου Λευκωσία

06/06/2026
https://www.facebook.com/share/1BgCwJfxGe/
12/05/2026

https://www.facebook.com/share/1BgCwJfxGe/

Vitamin K2 can help rebuild bone and decalcify soft tissue.

“Vitamin K2 treatment effectively prevents the occurrence of new fractures...” 🧑

“This systematic review suggests that supplementation with phytonadione and menaquinone-4 (K2 MK-4) reduces bone loss. In the case of the latter, there is a strong effect on incident fractures among Japanese patients.” 🧑

“45 mg (K2 MK4) was the minimum effective dose for improving bone mass parameters evaluated by microdensitometry and/or single photon absorptiometry in postmenopausal women with osteoporosis.” 🧑

“It may be suggested that a high dose of vitamin K2 suppressed experimental calcification of soft tissues induced by vitamin D2. Therefore, a pharmacological dose of vitamin K2 might have a usefulness for the prevention and treatment of arteriosclerosis with calcification.” 🐁

“This is the first study in rats demonstrating that arterial calcification and the resulting decreased arterial distensibility are reversible by high (K1 or K2). intake.” 🐁

Ref:
PMID: 10750566
PMID: 16801507
PMID: 24841104
Clinical evaluation of soft capsule menatetrenone (Ea-0167) in the treatment of osteoporosis. Late Phase II Dose Study
PMID: 8698544
PMID: 17138823

https://www.facebook.com/share/18ysvzizpc/
02/05/2026

https://www.facebook.com/share/18ysvzizpc/

A team led by Fang in 2016 (BMC Medicine) pooled 40 long-term population studies covering more than a million people. The question was straightforward. Does eating more magnesium track with lower cardiovascular disease?

For "cardiovascular disease" as a single category, the answer was no. For coronary heart disease specifically, also no. This is the headline that lives on every magnesium product label, and it does not survive the data.

For specific things, the same analysis found something different. For every additional 100 milligrams of magnesium per day, heart failure risk dropped about 22%. Stroke risk dropped about 7%. Type 2 diabetes risk dropped about 19%. Risk of death from any cause dropped about 10%.

100 milligrams of magnesium a day is roughly one ounce of pumpkin seeds, two thirds of a cup of cooked spinach, or an ounce of dark chocolate at 70% cacao or higher. The dose that moved the population numbers is small enough to live in a snack.

For depression, Tarleton and colleagues (2017, PLoS One) ran a 6-week study in 112 adults with mild to moderate depression. Participants took 248 milligrams of elemental magnesium per day, delivered as four magnesium chloride tablets, then crossed over to no treatment for another 6 weeks. Depression scores dropped about 6 points compared to the no-treatment phase. Five points is the threshold the scale uses for a clinically meaningful change. Magnesium cleared it within two weeks. There was no placebo group, which the authors flag directly. A placebo contribution to the effect cannot be ruled out.

For blood pressure, Zhang and colleagues (2016, Hypertension) pooled 34 trials covering about two thousand participants. These were the strongest design available, where neither the participants nor the researchers knew who got magnesium and who got a dummy pill. Magnesium dropped systolic blood pressure by about 2 points and diastolic by about 1.8, at a median dose of 368 milligrams per day for around three months. Modest, but consistent at doses as low as 300 milligrams per day.

For migraine, Talandashti and colleagues (2024, Neurological Sciences) pooled 22 trials across multiple supplements including magnesium, CoQ10, riboflavin, alpha-lipoic acid, probiotics, vitamin D, and omega-3. Magnesium specifically reduced migraine attacks by about 2.5 per month and reduced migraine days by about 1.66 per month compared to control.

One thing about lab tests. Standard blood work measures serum magnesium, which holds less than 1% of the magnesium in your body. About half to two thirds is locked in your bones. Most of the rest sits inside cells, where the enzymes actually function. A normal serum magnesium does not rule out a functional deficit. More sensitive tests exist, including ionized magnesium and red blood cell magnesium, but neither is on a standard panel. If you have asked your doctor for a magnesium test and been told everything is fine, that test has a known ceiling on what it can tell you.

The dietary lever is small and concrete. An ounce of pumpkin seeds delivers about 150 milligrams. Two thirds of a cup of cooked spinach delivers about 100 milligrams. An ounce of dark chocolate at 70% cacao delivers about 65 milligrams. Black beans, almonds, and avocado each contribute meaningful amounts per serving.

The point is not that everyone should rush to take a magnesium pill. The point is that "good for your heart" is a marketing line. The data is more specific. Heart failure yes. Coronary heart disease no. Stroke yes. Diabetes yes. Mortality yes. The categories that get marketed are not the categories the data measured.

de Baaij et al., Physiological Reviews, 2015
Tarleton et al., PLoS One, 2017
Zhang et al., Hypertension, 2016
Fang et al., BMC Medicine, 2016
Talandashti et al., Neurological Sciences, 2024

Address

33 Spyrou Kyprianou Avenue
Limassol
3070

Opening Hours

Monday 09:15 - 17:00
Tuesday 09:15 - 17:00
Wednesday 09:15 - 17:00
Thursday 09:15 - 17:00
Friday 09:15 - 17:00

Website

Alerts

Be the first to know and let us send you an email when Ιατρείο Γενικής Ιατρικής - Αλεπίδης Δημήτριος posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Ιατρείο Γενικής Ιατρικής - Αλεπίδης Δημήτριος:

Shortcuts

Share

Category